Skip to content

Author

Daniel S. Berman

3 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Oct 2026

Prediction of All-Cause Mortality, Cardiovascular Mortality, and Angiographic Coronary Disease From LVEF Reserve: Findings From the Multicenter REFINE PET Registry.

BACKGROUND Left ventricular ejection fraction reserve (LVEF-R), defined as stress EF minus rest EF, is a marker for high-risk coronary artery disease in patients undergoing positron emission tomography myocardial perfusion imaging, but its prognostic and diagnostic significance in large real-world populations remains i...

W. Hijazi, Jian-Hang Zhou, Robert J. H. Miller et al. · 0 citations
Open access Sep 2026

Artificial intelligence-derived splenic response in cardiac positron emission tomography is associated with major adverse cardiovascular events: a multi-site study.

AIMS Inadequate pharmacologic stress may limit the diagnostic and prognostic accuracy of myocardial perfusion imaging (MPI). The splenic ratio (SR), a measure of stress adequacy, has emerged as a potential imaging biomarker. We developed an artificial intelligence (AI) method to derive SR and evaluated the prognostic v...

G. Ramirez, Naga L. Dharmavaram, A. Shanbhag et al. · 0 citations
Review Sep 2026

Beyond stenosis: imaging phenotyping and risk stratification in nonobstructive coronary artery disease.

CCTA is evolving into a multidimensional phenotyping tool for NOCA; its immediate value is refined risk stratification; whether these markers will improve outcomes remains unproven and should be tested prospectively.

P. Piña, A. Filtz, Daniel Lorenzatti et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.